🇫🇷 SAN.PA — Sanofi

Healthcare Compra
← Volver

Precio actual

75,69 EUR

Máx. histórico

110,88

546 días

Caída desde máximo

-31,74%

Rango 52 semanas

71,25 – 91,15

Variación hoy

-0,75%

Cierre anterior

76,26

Rango de hoy

75,22 – 76,19

Volumen hoy

910.041

Información
Nombre completo
Sanofi
Divisa
EUR
Mercado
Paris
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
74.846
PER ⓘ
23,36 (puede no estar actualizado)
Dividend yield
5,40% (puede no estar actualizado)
Precio objetivo analistas
94,28 EUR (puede no estar actualizado)
Primera cotización
03/01/2000
Precio actualizado
hace 8 horas
Sobre la empresa

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Dividendos repartidos Total últimos 12 meses: 4,1200 EUR · Yield: 5,44%
Fecha de pago Importe por participación
05/05/2026 4,1200 EUR
12/05/2025 3,9200 EUR
13/05/2024 3,7600 EUR
30/05/2023 3,5600 EUR
06/05/2022 3,3300 EUR
05/05/2021 3,2000 EUR
04/05/2020 3,1500 EUR
09/05/2019 3,0700 EUR
11/05/2018 3,0300 EUR
16/05/2017 2,9600 EUR
10/05/2016 2,9300 EUR
11/05/2015 2,8500 EUR
12/05/2014 2,8000 EUR
09/05/2013 2,7700 EUR
10/05/2012 2,6500 EUR
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/04/2015 95,22 97,14 93,81 96,80 +1,53% 3,50% 2.845.095
24/04/2015 95,26 95,59 94,36 95,34 +0,53% 1,28% 2.781.957
23/04/2015 95,93 96,20 94,27 94,83 -1,18% 2,02% 3.442.335
22/04/2015 96,30 96,85 94,63 95,97 +0,60% 2,30% 2.670.135
21/04/2015 95,78 96,45 95,16 95,39 -0,26% 1,35% 2.742.473
20/04/2015 95,51 96,08 95,27 95,64 +0,53% 0,84% 2.579.627
17/04/2015 96,52 97,15 94,71 95,13 -1,41% 2,52% 4.216.531
16/04/2015 97,21 97,26 96,06 96,49 -1,26% 1,24% 3.341.019
15/04/2015 97,88 98,31 97,41 97,73 +0,35% 0,92% 2.419.221
14/04/2015 97,91 98,51 96,90 97,39 -1,07% 1,65% 3.237.380
13/04/2015 98,13 98,69 97,72 98,44 +0,23% 0,99% 2.540.492
10/04/2015 97,24 98,21 96,85 98,21 +1,64% 1,40% 2.452.662
09/04/2015 95,20 96,63 95,16 96,63 +1,63% 1,55% 2.690.248
08/04/2015 95,00 95,53 94,49 95,08 -0,19% 1,09% 2.384.005
07/04/2015 93,93 95,48 93,43 95,26 +2,19% 2,18% 3.217.590
02/04/2015 92,79 93,27 92,00 93,22 +0,86% 1,37% 2.484.484
01/04/2015 91,26 93,58 91,01 92,43 +1,09% 2,81% 2.756.564
31/03/2015 92,11 92,95 91,21 91,43 -0,83% 1,89% 3.286.827
30/03/2015 91,50 92,71 91,20 92,20 +1,10% 1,65% 2.363.205
27/03/2015 90,69 91,99 89,39 91,19 +0,34% 2,86% 3.762.808
26/03/2015 91,01 91,43 89,04 90,88 -0,82% 2,62% 3.937.796
25/03/2015 93,11 93,45 91,44 91,64 -2,02% 2,16% 3.154.167
24/03/2015 92,86 93,89 92,62 93,53 +0,58% 1,36% 2.430.199
23/03/2015 93,22 93,38 92,45 92,99 -0,14% 1,00% 2.437.939
20/03/2015 92,91 93,69 92,21 93,12 +0,70% 1,59% 5.662.801
19/03/2015 92,49 93,23 91,78 92,47 -0,09% 1,57% 3.278.817
18/03/2015 91,74 92,72 91,49 92,55 +0,89% 1,34% 2.587.546
17/03/2015 91,79 92,46 90,85 91,74 +0,18% 1,76% 3.701.595
16/03/2015 89,51 91,91 89,44 91,57 +2,49% 2,76% 3.645.293
13/03/2015 89,21 89,44 88,05 89,34 +0,37% 1,56% 2.731.171